Photo:
faculty.mdanderson.org
Jun 27, 2026, 13:40
Naveen Pemmaraju: Pacritinib Versus Momelotinib in Thrombocytopenic Myelofibrosis
Naveen Pemmaraju, Executive Director-Cancer Medicine for MDACC Cancer Network, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Expert Review of Hematology, adding:
“Pleased to share our brand new collaborative MPN paper just published in Expert Review of Hematology!”
Title: Efficacy of pacritinib versus momelotinib in patients with thrombocytopenic myelofibrosis: a matching-adjusted indirect treatment comparison
Authors: Naveen Pemmaraju, Alessandro Lucchesi, Stephen T Oh, Koo Wilson, Zalmai Hakimi, Sarah A Buckley, Purvi Suthar, Mikolaj Parkitny, Piotr Wojciechowski, Klaudia Kolonko, John O Mascarenhas

Stay updated on all scientific advances with Hemostasis Today.
Alessandro Lucchesi
Expert Review of Hematology
Health
Hematology
Hemostasis
Hemostasis News
Hemostasis Today
John O Mascarenhas
Klaudia Kolonko
Koo Wilson
Medicine
Mikolaj Parkitny
Momelotinib
MPN
Naveen Pemmaraju
Pacritinib
Piotr Wojciechowski
Purvi Suthar
Sarah A Buckley
Stephen T Oh
thrombosis
Zalmai Hakimi
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments